510(k) · Cleared
ClearedCrux Vena Cava Filter System, femoral; Crux Vena Cava Filter System, jugular
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Volcano Corporation · DTK Filter, Intravascular, Cardiovascular
Cleared on Apr 3, 2015 as substantially equivalent to K122585 (Crux Biomedical, 2013) after a 58-day review. Its family tree reaches back 8 generations to 1990. 1 of the 27 devices in its family, counting itself, has a Class I recall.
- Decided
- Apr 3, 2015
- Review
- 58 days
- Class
- Class II
- Product code
- DTK
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 8 generations to K901502 (1990). 26 ancestors in all. No later device cites it as a predicate yet. 1 of the 27 devices in this family, counting this one, has a Class I recall.
- Root · 8 generations backK901502 Amplatz Goose-Neck SnareMicrovena Corp. · 1990 · Recalled
- 7 generations backK972511 Amplatz Goose Neck Snare Kit/ CatheterMicrovena Corp. · 1998 · Recalled
- 6 generations backK021441 Radius SnareRadius Medical Technologies, Inc. · 2002
- 5 generations backK022201 Radius Micro SnareRadius Medical Technologies, Inc. · 2003
- 4 generations backK032426 Gunhter Tulip Vena Cava Mreye Filter and Retrieval SetCook, Inc. · 2003
- 3 generations backK081410 Option Vena Cava FilterRex Medical · 2009
- 2 generations backK120402 Crux Vena Cava Filter SystemCrux Biomedical · 2012
- 1 generation backK122585 Crux Vena Cava Filter SystemCrux Biomedical · 2013
- This deviceK150262 Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System…Volcano Corporation · 2015
Class I recalls in this family
- K970466 Radius Ptca Guidewire6 generations back · 1997
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −8 | K901502 | Amplatz Goose-Neck Snare | Microvena Corp. | 1990 | 1 |
| −7 | K972511 | Amplatz Goose Neck Snare Kit/ Catheter | Microvena Corp. | 1998 | 1 |
| −6 | K021441 | Radius Snare | Radius Medical Technologies, Inc. | 2002 | — |
| −5 | K022201 | Radius Micro Snare | Radius Medical Technologies, Inc. | 2003 | — |
| −4 | K032426 | Gunhter Tulip Vena Cava Mreye Filter and Retrieval Set | Cook, Inc. | 2003 | — |
| −3 | K081410 | Option Vena Cava Filter | Rex Medical | 2009 | — |
| −2 | K120402 | Crux Vena Cava Filter System | Crux Biomedical | 2012 | — |
| −1 | K122585 | Crux Vena Cava Filter System | Crux Biomedical | 2013 | — |
| 0 (this device) | K150262 | Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System, jugular | Volcano Corporation | 2015 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1993 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 1 |
| 1998 | 1 | 0 |
| 2000 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
| 2008 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DTK device
- #1 K242612 Option ELITE Vena Cava Filter System…score 10.1 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K122585 | Crux Vena Cava Filter SystemSummary page 4…IFICATION: 21 CFR 870.3375 Class II Device PANEL: Cardiovascular PREDICATE DEVICE: Crux Vena Cava Filter System, K122585 DEVICE DECRISPTION: The Crux Vena Cava Filter (VCF) System is an endovascular medical device used in the preventi… | 2013 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (1 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K970466Radius Ptca GuidewireRadius Medical Technologies, Inc. · 1997 · 6 generations back · ◆ in the 1997 ancestors bar of FIG. 12 Class I recalls
What does this lineage say?
- The line of descent spans 25 years and passes through 6 companies; a new generation was cleared every 3.1 years on median.
- 5 of the 26 ancestors have a recall of any class; 1 has a Class I recall.
How does its category compare?
All DTK devicesDTK Filter, Intravascular, Cardiovascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.
FDA decisions per year · DTK
5in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · DTK
29in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DTK
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DTK
432in 2025
MAUDE reports naming product code DTK, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 87 | 1 | 364 |
| 2008 | 6 | 87 | 0 | 345 |
| 2009 | 3 | 380 | 0 | 456 |
| 2010 | 3 | 50 | 0 | 369 |
| 2011 | 2 | — | 0 | 439 |
| 2012 | 5 | 156 | 0 | 351 |
| 2013 | 3 | 91 | 1 | 473 |
| 2014 | 2 | — | 0 | 451 |
| 2015 | 2 | — | 1 | 859 |
| 2016 | 3 | 84 | 2 | 2,574 |
| 2017 | 5 | 88 | 0 | 4,364 |
| 2018 | 2 | — | 0 | 3,938 |
| 2019 | 0 | — | 6 | 6,467 |
| 2020 | 0 | — | 0 | 5,405 |
| 2021 | 2 | — | 0 | 5,357 |
| 2022 | 0 | — | 2 | 2,191 |
| 2023 | 0 | — | 0 | 583 |
| 2024 | 5 | 29 | 0 | 406 |
| 2025 | 0 | — | 1 | 432 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Crux Vena Cava Filter (VCF) System is indicated for the prevention of recurrent pulmonary embolism via placement in the inferior vena cava (IVC) in the following situations: • pulmonary thromboembolism when anticoagulants are contraindicated; • failure of anticoagulant therapy in thromboembolic disease; • emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced; • chronic, recurrent…
Read the full statement (113 words)
The Crux Vena Cava Filter (VCF) System is indicated for the prevention of recurrent pulmonary embolism via placement in the inferior vena cava (IVC) in the following situations:
• pulmonary thromboembolism when anticoagulants are contraindicated;
• failure of anticoagulant therapy in thromboembolic disease;
• emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced;
• chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated.
The Crux VCF may be removed according to the instructions contained in the section “Optional Retrieval of the Crux VCF” in patients who no longer require a vena cava filter. Retrieval of the filter can be performed by femoral or jugular approach.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K150262 · printed Nov 6, 2026
Cite this page
510(k) Report. “K150262: Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System, jugular.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150262
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026